Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Baricitinib is effective and safe for treating severe alopecia areata.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Certain cancer drugs can cause skin issues like rashes and itching.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Clitocybin A can promote hair growth by increasing cell proliferation.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Clascoterone may be a promising treatment for hair loss.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Researchers developed a scaffold that releases a healing drug over time, improving wound healing and skin regeneration.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Baricitinib is effective and safe for treating severe alopecia areata.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.